About
- About Avecho
- Board & Leadership
TPM^® Technology
Portfolio
Invest
- Investor Centre
- Media Centre
Contact

Hit enter to search or ESC to close

Phosphagenics Announces Results of TPM Oxycodone Phase 2a Trial

January 29, 2016

Click here to read more

Post navigation

Phosphagenics Reports Positive Resuls for Weaner Pig Efficiency Trial

Phosphagenics Newsletter – February 2016

Related Posts

2017 Annual Report

March 28, 2018

2016 Sep 12 Phosphagenics Updates Long Term Incentive Scheme

September 12, 2016

Results for Phase I human clinical trial of CBD soft-gel product

December 8, 2021December 8, 2021

Recent Posts

Media Coverage | Nine News
October 21, 2024
First Patient Dosed in Phase III Insomnia Trial
May 16, 2024
MEDIA | Channel 9 News
March 28, 2024

Categories

Analyst Coverage
Company Announcement
Company Report
Media Coverage
Newsletter
Press Release
Uncategorised

About us

We see a future where more patients can get even more from their treatments through innovative delivery technologies.

Stay Posted

Stay informed about our latest news and developments.

Leave this field empty if you're human:

About Avecho

TPM^® Technology

Portfolio

Investor Centre
- Investor Centre
- Media Centre

© Copyright 2019 Avecho Biotechnology Ltd.